Sunitinib Induced Immune Thrombocytopenia

Sunitinib is an oral tyrosine kinase inhibitor which prevents tumor growth and metastatic progression. It was approved for treatment of advanced renal cell cancer, gastrointestinal stromal tumor and advanced pancreatic neuroendocrine tumors. It has several adverse reactions on multi organ systems in...

Descripción completa

Detalles Bibliográficos
Autores principales: Shekarriz, Ramin, Koulaeinejad, Neda, Nosrati, Anahita, Salehifa, Ebrahim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shaheed Beheshti University of Medical Sciences 2015
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673961/
https://www.ncbi.nlm.nih.gov/pubmed/26664400

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673961/
https://www.ncbi.nlm.nih.gov/pubmed/26664400

Ejemplares similares